Fraxiparine

Fraxiparine is a medication containing Nadroparin Calcium, used for anticoagulation. It is administered via haemodialysis, intravenous, or subcutaneous routes. This product is manufactured by Viatris Healthcare NV/SA in the EU.

Fraxiparine is commonly used to prevent blood clots in various medical conditions. It is often prescribed for patients undergoing surgery or those with limited mobility. The medication works by thinning the blood, reducing the risk of clot formation. What is Fraxiparine used for? It is primarily used for anticoagulation to prevent deep vein thrombosis and pulmonary embolism.

Common effects of Fraxiparine may include bruising, bleeding, and pain at the injection site. Some users might experience allergic reactions or unusual bleeding. It is important to monitor for signs of excessive bleeding while using this medication.

Fraxiparine should be handled with care to avoid contamination. It is essential to follow the prescribed dosage and administration instructions. Patients with a history of bleeding disorders or recent surgery should consult their healthcare provider before use. Proper storage conditions should be maintained to ensure the medication's effectiveness.

Fraxiparine may interact with other blood-thinning medications, increasing the risk of bleeding. It is important to inform your healthcare provider about all medications, including over-the-counter drugs and supplements, before starting Fraxiparine. Alcohol consumption should be limited as it can enhance the effects of the medication.